Hospital pharmacies might expect a new antibiotic, dalbavancin, to be available soon, since the FDA sent Pfizer Inc. an approvable letter in late December 2007.
Hospital pharmacies might expect a new antibiotic, dalbavancin, to be available soon, since the FDA sent Pfizer Inc. an approvable letter in late December 2007.
Dalbavancin is expected to have FDA approval soon
May 1, 2008